|Category||Female Lower Urinary Tract Symptoms (LUTS) / Voiding Dysfunction|
|Keywords||sacral neuromodulation posterior tibial nerve stimulation lower urinary tract symptoms|
|Target Audience||Urology, Urogynaecology and Female & Functional Urology, Basic Science|
|Aims and Objectives|
Sacral Neuromodulation (SNM) has had FDA approval for the management of overactive bladder (OAB) and chronic non obstructive urinary retention for greater than 20 years. Since then posterior tibial nerve stimulation was introduced and predominantly is used to treat refractory OAB. In recent years several innovative developments have taken place in this field with additional benefits. The purpose of this workshop is to review the current status of neuromodulation in managing lower urinary tract dysfunction with a particular focus on evidence published in the last 5-10 years, discuss ways of optimising neuromodulation for the benefit of patients, discuss the new innovations and where the technology is heading in the future.